These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 21847633

  • 1. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
    Jia XQ, Cheng HQ, Qian X, Bian CX, Shi ZM, Zhang JP, Jiang BH, Feng ZQ.
    Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
    [Abstract] [Full Text] [Related]

  • 2. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu H, Lian J, Chen L, Han J.
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [Abstract] [Full Text] [Related]

  • 3. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q, Chen X, Lu F, Zhang T, Hao M, Wang Y, Zhao J, McCrae MA, Zhuang H.
    Cancer; 2012 May 01; 118(9):2431-42. PubMed ID: 21989846
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms.
    Dai M, Chen N, Li J, Tan L, Li X, Wen J, Lei L, Guo D.
    Phytomedicine; 2021 Jul 12; 87():153580. PubMed ID: 34029939
    [Abstract] [Full Text] [Related]

  • 6. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH, Shan H, Li D, Zhou B, Pang PF.
    Cell Biochem Funct; 2017 Mar 12; 35(2):98-104. PubMed ID: 28261837
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
    Gastroenterology; 2009 Feb 12; 136(2):683-93. PubMed ID: 19027010
    [Abstract] [Full Text] [Related]

  • 8. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.
    Cancer Res; 2010 Jun 15; 70(12):5184-93. PubMed ID: 20501828
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL.
    FEBS J; 2015 Feb 15; 282(3):579-94. PubMed ID: 25475121
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F.
    Liver Int; 2012 May 15; 32(5):752-60. PubMed ID: 22276989
    [Abstract] [Full Text] [Related]

  • 11. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan C, Liu S, Zhang Y.
    PLoS One; 2014 May 15; 9(12):e115565. PubMed ID: 25531114
    [Abstract] [Full Text] [Related]

  • 12. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P, Chen S, Fang H, Wu X, Chen D, Peng L, Gao Z, Xie C.
    Oncotarget; 2016 Jan 05; 7(1):929-45. PubMed ID: 26498144
    [Abstract] [Full Text] [Related]

  • 13. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.
    Proteomics; 2010 Oct 05; 10(20):3723-31. PubMed ID: 20859956
    [Abstract] [Full Text] [Related]

  • 14. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X, Chen J, Li F, Lin Y, Zhang X, Lv Z, Jiang J.
    Biochem Biophys Res Commun; 2012 Nov 30; 428(4):525-31. PubMed ID: 23068095
    [Abstract] [Full Text] [Related]

  • 15. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.
    Int J Biochem Cell Biol; 2012 Dec 30; 44(12):2321-32. PubMed ID: 22903020
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun 30; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 17. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 30; 20(8):598-604. PubMed ID: 23207154
    [Abstract] [Full Text] [Related]

  • 18. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
    Fan Q, He M, Deng X, Wu WK, Zhao L, Tang J, Wen G, Sun X, Liu Y.
    Cell Biochem Funct; 2013 Jun 30; 31(4):319-24. PubMed ID: 23001723
    [Abstract] [Full Text] [Related]

  • 19. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.
    Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, Gao Z, Xie F, He C, Deng Z, Yang BB.
    FASEB J; 2013 Mar 30; 27(3):907-19. PubMed ID: 23180826
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.
    J Hepatol; 2012 Sep 30; 57(3):584-91. PubMed ID: 22613005
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.